Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03220932
Title Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer (HIPOVA-01)
Recruitment Not yet recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Hospices Civils de Lyon
Indications

ovarian carcinoma

Therapies

Bevacizumab

Cisplatin

Age Groups: senior | adult
Covered Countries


No variant requirements are available.